Using AI to improve understanding and diagnosis of Alzheimer's Disease
Official title: Explainable and Ethical AI for Studying Alzheimer's Disease
Funded at Emory University · NIH-11142558 · Data updated 2026-11-12
This study is working on using smart computer technology to help doctors better understand and diagnose Alzheimer's Disease by looking at brain scans and other health information, so patients can get more accurate and fair assessments of their condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | August 1, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $609,798 |
| NIH project number | 5R01AG089806-02 |
| Project ID | NIH-11142558 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease, particularly those from diverse racial and socioeconomic backgrounds.
✕Less likely to help
Patients without a diagnosis of Alzheimer's Disease or those who do not have access to the necessary healthcare resources may not benefit from this research.
What this research studies
This research focuses on developing advanced artificial intelligence (AI) models to enhance the diagnosis and prognosis of Alzheimer's Disease (AD). It aims to address the challenges of explainability in AI, ensuring that factors such as race, social determinants of health, and comorbidities are considered in the models. By analyzing cerebrospinal fluid proteomics alongside brain imaging data, the research seeks to uncover patterns that can lead to better patient management and understanding of AD. Patients may benefit from more accurate and ethical AI-driven assessments of their condition.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and ethical AI tools for diagnosing and managing Alzheimer's Disease, ultimately improving patient outcomes.
How similar studies have gone: Previous research has shown promise in using AI for medical diagnostics, but this approach specifically addressing explainability and ethical considerations in Alzheimer's Disease is relatively novel.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Qiu, Deqiang — Emory University
- Study coordinator: Qiu, Deqiang
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.